<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Advances in the care of the critically ill neonate have necessitated dramatic changes in the blood bank’s response, especially to the needs of the low-weight premature infant. The neonate is now considered a major consumer of blood products, and the packaging and administration of these products must be altered to suit its specialized needs. The indications and preparations for small-volume red blood cell (RBC) transfusions are of particular concern. Smallvolume RBC transfusions are both the most frequently used and the most controversial in the treatment of neonates. A review and guidelines for the use of RBCs for the perinatal patient are presented. <bold><italic>Immunobematology</italic></bold> 1991; 1:1–7.</p></abstract>

Advances in the care of the critically ill neonate have necessitated dramatic changes in the blood bank’s response, especially to the needs of the low-weight premature infant. The neonate is now considered a major consumer of blood products, and the packaging and administration of these products must be altered to suit its specialized needs. The indications and preparations for small-volume red blood cell (RBC) transfusions are of particular concern. Smallvolume RBC transfusions are both the most frequently used and the most controversial in the treatment of neonates. A review and guidelines for the use of RBCs for the perinatal patient are presented. Immunobematology 1991; 1:1–7.

A review: controversies in blood component use in newborns

Immunohematology

{"article-title":"A review: controversies in blood component use in newborns"}

Advances in the care of the critically ill neonate have necessitated dramatic changes in the blood bank’s response, especially to the needs of the low-weight...

A review: controversies in blood component use in newborns

Published Online: Dec 14, 2020

Page range: 1 - 7

DOI: https://doi.org/10.21307/immunohematology-2019-1001

© 1991 N.L.C. Luban published by Sciendo